High-glucose and advanced glycosylation end products increased podocyte permeability via PI3-K/Akt signaling

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Journal of molecular medicine

• Publication date

  2010-01-08

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s00109-009-0575-8PMID 20054520
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Receptor for AGE (RAGE) and its ligands—cast into leading roles in diabetes and the inflammatory response

  2009cited by this paper
• Podocytes in culture: past, present, and future.

  2007cited by this paper
• ZO-1 expression and phosphorylation in diabetic nephropathy.

  2006influential reference
• Key molecular events in puromycin aminonucleoside nephrosis rats

  2004cited by this paper
• Effects of advanced glycosylation endproducts on perlecan core protein of glomerular epithelium

  2004cited by this paper
• Podocyte changes upon induction of albuminuria in Thy-1.1 transgenic mice.

  2003influential reference
• The phosphoinositide (PI) 3-kinase family

  2003cited by this paper
• Signal transduction pathways in mouse microglia N‐11 cells activated by advanced glycation endproducts (AGEs)

  2003cited by this paper
• Glucose, glycation, and RAGE: implications for amplification of cellular dysfunction in diabetic nephropathy.

  2003cited by this paper
• Neph1 and nephrin interaction in the slit diaphragm is an important determinant of glomerular permeability.

  2003cited by this paper
• Podocyte process effacement in vivo

  2002cited by this paper
• Podocyte biology and response to injury.

  2002cited by this paper
• Phosphoinositide 3-kinase in immunological systems.

  2002cited by this paper
• Expression of advanced glycation end products and their cellular receptor RAGE in diabetic nephropathy and nondiabetic renal disease.

  2000cited by this paper
• Effect of glucose on intercellular junctions of cultured human peritoneal mesothelial cells.

  2000cited by this paper
• Effect of angiotensin-converting enzyme inhibition on glomerular basement membrane permeability and distribution of zonula occludens-1 in MWF rats.

  2000cited by this paper
• Phosphatidylinositol 3-Kinase Function Is Required for Transforming Growth Factor β-mediated Epithelial to Mesenchymal Transition and Cell Migration*

  2000cited by this paper
• The glomerular slit diaphragm is a modified adherens junction.

  2000cited by this paper
• A simple method to detect an albumin permeability factor in the idiopathic nephrotic syndrome.

  2000cited by this paper
• Protein kinase B (c-Akt): a multifunctional mediator of phosphatidylinositol 3-kinase activation.

  1998cited by this paper
• Regulation of podocyte structure during the development of nephrotic syndrome

  1998cited by this paper
• Involvement of ZO-1 in Cadherin-based Cell Adhesion through Its Direct Binding to α Catenin and Actin Filaments

  1997cited by this paper
• A quantitative immunofluorescence study of glomerular cell adhesion proteins in proteinuric states

  1997cited by this paper
• Slit diaphragm-reactive nephritogenic MAb 5-1-6 alters expression of ZO-1 in rat podocytes.

  1997cited by this paper
• Rearrangements of the cytoskeleton and cell contacts induce process formation during differentiation of conditionally immortalized mouse podocyte cell lines.

  1997cited by this paper
• Biochemical events and cytokine interactions linking glucose metabolism to the development of diabetic nephropathy.

  1997cited by this paper
• Slit diaphragm-reactive nephritogenic MAb 5-1-6 alters expression of ZO-1 in rat podocytes.

  1997cited by this paper
• Protein glycation in the kidney: role in diabetes and aging.

  1996cited by this paper
• Structure and function of podocytes: an update

  1995cited by this paper
• Monoclonal antibody 7H6 reacts with a novel tight junction-associated protein distinct from ZO-1, cingulin and ZO-2

  1993cited by this paper
• The altered glomerular filtration slits seen in puromycin aminonucleoside nephrosis and protamine sulfate-treated rats contain the tight junction protein ZO-1.

  1992cited by this paper
• Identification of a 160-kDa polypeptide that binds to the tight junction protein ZO-1.

  1991cited by this paper
• The tight junction protein ZO-1 is concentrated along slit diaphragms of the glomerular epithelium

  1990cited by this paper
• Identification of ZO-1: a high molecular weight polypeptide associated with the tight junction (zonula occludens) in a variety of epithelia

  1986cited by this paper
• Isolation and characterization of rat glomerular epithelial cells in vitro.

  1978cited by this paper

• Crosstalk between ferroptosis and innate immune in diabetic kidney disease: mechanisms and therapeutic implications

  2025cites this paper
• AGE/RAGE in diabetic kidney disease and ageing kidney.

  2021cites this paper
• Identification of miRNAs-genes regulatory network in diabetic nephropathy based on bioinformatics analysis

  2019cites this paper
• Eucalyptol Inhibits Advanced Glycation End Products‐Induced Disruption of Podocyte Slit Junctions by Suppressing Rage‐Erk‐C‐Myc Signaling Pathway

  2018cites this paper
• Montelukast improves the changes of cytoskeletal and adaptor proteins of human podocytes by interleukin-13

  2017cites this paper
• Puromycin aminonucleoside increases podocyte permeability by modulating ZO-1 in an oxidative stress-dependent manner.

  2016cites this paper
• CD2-associated protein/phosphoinositide 3-kinase signaling has a preventive role in angiotensin II-induced podocyte apoptosis.

  2016cites this paper
• Regulation of Podocyte apoptosis in Diabetic Kidney Disease - Role of SHIP2, PDK1 and CDK2

  2016cites this paper
• Role of vitamin D in improvement in changes of podocyte P-cadherin/β-catenin complex induced by diabetic conditions.

  2015cites this paper
• Diabetic conditions downregulate the expression of CD2AP in podocytes via PI3‐K/Akt signalling

  2015cites this paper
• The expression and function of RAGE and HMGB1 in airway structural cells in asthma

  2015cites this paper
• Effects of Interleukin-13 and Montelukast on the Expression of Zonula Occludens-1 in Human Podocytes

  2015cites this paper
• β-catenin and its alteration in an experimental model of diabetic nephropathy.

  2014cites this paper
• Fluorofenidone Offers Improved Renoprotection at Early Interventions during the Course of Diabetic Nephropathy in db/db Mice via Multiple Pathways

  2014cites this paper
• Interleukin-13 may increase podocyte permeability via modulation of zonula occludens-1

  2013cites this paper
• Changes of podocyte p130Cas in diabetic conditions.

  2013cites this paper
• Curcumin ameliorates methylglyoxal-induced alterations of cellular morphology and hyperpermeability in human umbilical vein endothelial cells

  2013cites this paper
• Roles of adaptor proteins in podocyte biology.

  2013cites this paper
• Angiotensin II suppresses adenosine monophosphate-activated protein kinase of podocytes via angiotensin II type 1 receptor and mitogen-activated protein kinase signaling

  2013cites this paper
• Puromycin aminonucleoside modulates p130Cas of podocytes

  2012cites this paper
• Advanced glycation end-products activate the renin-angiotensin system through the RAGE/PI3-K signaling pathway in podocytes.

  2012cites this paper
• Diabetic Nephropathy AGE , RAGE , and Diabetic Nephropathy

  2012cites this paper
• Acute and sustained actions of hyperglycaemia on endothelial and glomerular barrier permeability

  2012influential citation
• Ginseng Total Saponin Improves Podocyte Hyperpermeability Induced by High Glucose and Advanced Glycosylation Endproducts

  2011cites this paper
• AGE, RAGE, and Diabetic Nephropathy

  2010cites this paper
• Podocytes, glucose and insulin

  2010cites this paper